Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Cui, Huixian  [Clear All Filters]
2019
Ma J, Guo R, Song Y, Zhang J, Feng B, Amponsah AErnest, Kong D, He J, Zhang W, Liu A, et al. Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient. Stem Cell Res. 2019;36:101417.
2020
Amponsah AErnest, Feng B, Guo R, Zhang W, He J, Kong D, Dong T, Ma J, Cui H. Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease. Rev Neurosci. 2020.
Yang M, Liu M, Ding Y, Vajda A, Ma J, Cui H, O'Brien T, Henshall D, Hardiman O, Shen S. Generation of twelve induced pluripotent stem cell lines from two healthy controls and two patients with sporadic amyotrophic lateral sclerosis. Stem Cell Res. 2020;44:101752.
Feng B, Ma J, Amponsah AErnest, Guo R, Kong D, He J, Jiang Y, Zhang W, Zhang Z, Song Y, et al. Induced pluripotent stem cell line derived from a sporadic amyotrophic lateral sclerosis patient. Stem Cell Res. 2020;45:101841.
Hao P, Yue F, Xian X, Ren Q, Cui H, Wang Y. Inhibiting effect of MicroRNA-3619-5p/PSMD10 axis on liver cancer cell growth in vivo and in vitro. Life Sci. 2020:117632.
Ma J, Feng B, Kong D, He J, Guo R, Amponsah AErnest, Zhang W, Zhang S, Lv F, Song Y, et al. Production and validation of human induced pluripotent stem cell line from sporadic amyotrophic lateral sclerosis (SALS). Stem Cell Res. 2020;44:101760.
2021
Guo R, Mu W, Liu X, Zhang J, Liu B, Du X, He J, Ma J, Cui H. Reprogramming of a human induced pluripotent stem cell line from one 48-year-old healthy male donor. Stem Cell Res. 2021;53:102339.
2022
Guo R, Liu X, Zhang J, Ma X, Gou D, Ma Z, Wang L, Ma J, Cui H. Integration-free induced pluripotent stem cell line derived from a 62-years-old male donor with APOE-epsilon4/epsilon4 alleles. Stem Cell Res. 2022;61:102746.
Zhang R, Gao Y, Li Y, Geng D, Liang Y, He Q, Wang L, Cui H. Nrf2 improves hippocampal synaptic plasticity, learning and memory through the circ-Vps41/miR-26a-5p/CaMKIV regulatory network. Exp Neurol. 2022:113998.
2023
Guo R, Chen Y, Zhang J, Zhou Z, Feng B, Du X, Liu X, Ma J, Cui H. Neural Differentiation and spinal cord organoid generation from induced pluripotent stem cells (iPSCs) for ALS modelling and inflammatory screening. Mol Neurobiol. 2023.
Zhou Z, Shi B, Xu Y, Zhang J, Liu X, Zhou X, Feng B, Ma J, Cui H. Neural stem/progenitor cell therapy for Alzheimer disease in preclinical rodent models: a systematic review and meta-analysis. Stem Cell Res Ther. 2023;14(1):3.
Liu B, Zhang J, Zhou Z, Feng B, He J, Yan W, Zhou X, Amponsah AErnest, Guo R, Du X, et al. Preclinical Evidence for the Effectiveness of Mesenchymal Stromal Cells for Diabetic Cardiomyopathy: A Systematic Review and Meta-Analysis. Curr Stem Cell Res Ther. 2023.
Zhang J, Fang S, Rong F, Jia M, Wang Y, Cui H, Hao P. PSMD4 drives progression of hepatocellular carcinoma via Akt/COX2 pathway and p53 inhibition. Hum Cell. 2023.
2024
Du X, Kong D, Guo R, Liu B, He J, Zhang J, Amponsah AErnest, Cui H, Ma J. Combined transplantation of hiPSC-NSC and hMSC ameliorated neuroinflammation and promoted neuroregeneration in acute spinal cord injury. Stem Cell Res Ther. 2024;15(1):67.
Asiamah EAmponsah, Feng B, Guo R, Yaxing X, Du X, Liu X, Zhang J, Cui H, Ma J. The Contributions of the Endolysosomal Compartment and Autophagy to APOEɛ4 Allele-Mediated Increase in Alzheimer's Disease Risk. J Alzheimers Dis. 2024;97(3):1007-1031.